Search results
(360) 650-3145. Research Interests. My research interests are in the areas of surface and materials chemistry, with an emphasis on the development of new heterogeneous catalysts for the production of clean and renewable fuels, and the selective hydrogenation of alkynes.
After six months of continued success alleviating patients’ neuropathic symptoms from diabetes, trauma, and idiopathic neuropathy, the program was made permanent. A new, expanded treatment center will allow Mark to help many more patients enjoy a life without pain or numbness.
Articles 1–20. Professor of Chemistry, Western Washington University - Cited by 5,181 - heterogeneous catalysis - metal phosphides - hydrotreating - photocatalysis.
Dr. Mark Bussell, developer of the INF® Treatment, has successfully treated thousands of patients at Loma Linda University Medical Center since 2011. Dr. Bussell first developed this treatment to help his son's struggle with epilepsy and treat his own chemotherapy-induced neuropathy.
Jul 24, 2023 · Western Washington University Professor of Chemistry Mark Bussell has been elected to the Washington State Academy of Sciences, and will be inducted at the 16th Annual Members Meeting in Spokane on Sept. 13.
View Mark Bussell’s profile on LinkedIn, the world’s largest professional community. Mark has 6 jobs listed on their profile.
- 449 followers
Mark BUSSELL, Professor | Cited by 3,817 | of Western Washington University, Washington (WWU) | Read 58 publications | Contact Mark BUSSELL.
